Darcy Bomford, Chief Executive Officer and Director of True Leaf, will be giving a presentation, participate in a panel and meet with investors throughout the conference.
Vernon, BC – (December 5, 2017) – True Leaf Medicine International Ltd. (“True Leaf”) (CSE: MJ) (FSE: TLA) (OCTQB: TRLFF) today announced it will present at the LD Micro 10th Annual Main Event being held in Los Angeles, CA on December 5-7, 2017. Darcy Bomford, Chief Executive Officer and Director of True Leaf, will be giving a presentation, participate in a panel and meet with investors throughout the conference.
Mr. Bomford will discuss the progress of True Leaf’s current Regulation A+ equity crowdfunding offering. More information about the offering is available at invest.trueleaf.com. Boustead Securities, LLC is serving as lead underwriter for the offering.
Event: LD Micro 10th Annual Main Event
Date: Wednesday, December 6, 2017
Time: 3:30pm PT (Pacific Time)
Location: Track 5, Luxe Sunset Boulevard Hotel, Los Angeles, CA
Also on December 6, Mr. Bomford will participate in a panel at the conference titled, “High Times Panel – Cannabis in 2025: How has the cannabis landscape changed? How large is the market? Where is it legal? What regulatory changes have taken effect?” The panel will be moderated by Adam Levin, CEO of High Times, and in addition to Mr. Bomford, panelists include Alan Lien, CEO of SolisTek, Hadley Ford, CEO of iAnthus Capital Holdings, Derek Peterson, CEO of TerraTech, and Nick Kovacevich, CEO of Kush Bottles.
LD Micro was founded in 2006 with the sole purpose of being an independent resource in the microcap space.
For investors attending the LD Micro Conference, please contact True Leaf Investor Relations to schedule a meeting with True Leaf management at [email protected]
